Kairos Pharma (KAPA) Interest Coverage Ratio (2023 - 2025)
Kairos Pharma's (KAPA) quarterly Interest Coverage Ratio came in at 7.58 in Q2 2025, up 59.01% YoY from 4.77 in Q2 2024, and down 72.51% on a QoQ basis from 4.4 in Q1 2025.
Kairos Pharma (KAPA) Interest Coverage Ratio (2023 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 3 years of Interest Coverage Ratio data on file, last reported at 7.58 in Q2 2025.
- Quarterly Interest Coverage Ratio rose 59.01% year-over-year to 7.58 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 23.7 (up 42.16% YoY) and the FY2025 annual result came in at 1.85, up 33.53% from the prior year.
- Interest Coverage Ratio declined to 7.58 in Q2 2025, from 4.4 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.71 in Q3 2024 to a low of 363.0 in Q4 2023.
- A 3-year average of 54.19 and a median of 12.76 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio jumped 99.37% — and 2025, when it jumped 59.01%.
- Tracing KAPA's Interest Coverage Ratio over 3 years: stood at 363.0 in 2023, then jumped by 99.37% to 2.28 in 2024, then sank by 233.02% to 7.58 in 2025.
- The last three Interest Coverage Ratio figures came in at 7.58 (Q2 2025), 4.4 (Q1 2025), and 2.28 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 1.42 |
| 10 | Kairos Pharma | 5.52 Mn | 188,650.70 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -7.58 |
| Mar 31, 2025 | -4.40 |
| Dec 31, 2024 | -2.28 |
| Sep 30, 2024 | -0.71 |
| Jun 30, 2024 | -18.50 |
| Mar 31, 2024 | -17.94 |
| Dec 31, 2023 | -363.00 |
| Sep 30, 2023 | -19.13 |